Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mukta Arora

Showing results (111-120 of 168) with videos related to

Pageof 17
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 10, 2013
Pulmonary symptoms measured by the national institutes of health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in chronic graft-versus-host diseaseJeanne Palmer, Kirsten Williams, Yoshihiro Inamoto, et al.
JAMA Oncology|September 9, 2021
Trends in Late Mortality and Life Expectancy After Allogeneic Blood or Marrow Transplantation Over 4 Decades: A Blood or Marrow Transplant Survivor Study ReportSmita Bhatia, Chen Dai, Wendy Landier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 2008
Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemiaTheresa Hahn, Philip L McCarthy, Mei-Jie Zhang, et al.
Blood|June 10, 2011
Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS)Saro H Armenian, Can-Lan Sun, Toana Kawashima, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2016
Biomarker Panel for Chronic Graft-Versus-Host DiseaseJeffrey Yu, Barry E Storer, Kushi Kushekhar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 14, 2009
Sibling versus unrelated donor allogeneic hematopoietic cell transplantation for chronic myelogenous leukemia: refined HLA matching reveals more graft-versus-host disease but not less relapseDaniel J Weisdorf, Gene Nelson, Stephanie J Lee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 9, 2018
Employment, Insurance, and Financial Experiences of Patients with Chronic Graft-versus-Host Disease in North AmericaNandita Khera, Betty K Hamilton, Joseph A Pidala, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 22, 2020
Current Use of and Trends in Hematopoietic Cell Transplantation in the United StatesAnita D'Souza, Caitrin Fretham, Stephanie J Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2022
Axatilimab for Chronic Graft-Versus-Host Disease After Failure of at Least Two Prior Systemic Therapies: Results of a Phase I/II StudyCarrie L Kitko, Mukta Arora, Zachariah DeFilipp, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 12, 2020
Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic AnemiaMary Eapen, Mei-Jie Zhang, Xiao-Ying Tang, et al.
Pageof 17

Showing results (111-120 of 168) with videos related to

Sort By:
Pageof 17
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 10, 2013
Pulmonary symptoms measured by the national institutes of health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in chronic graft-versus-host diseaseJeanne Palmer, Kirsten Williams, Yoshihiro Inamoto, et al.
JAMA Oncology|September 9, 2021
Trends in Late Mortality and Life Expectancy After Allogeneic Blood or Marrow Transplantation Over 4 Decades: A Blood or Marrow Transplant Survivor Study ReportSmita Bhatia, Chen Dai, Wendy Landier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 2008
Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemiaTheresa Hahn, Philip L McCarthy, Mei-Jie Zhang, et al.
Blood|June 10, 2011
Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS)Saro H Armenian, Can-Lan Sun, Toana Kawashima, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2016
Biomarker Panel for Chronic Graft-Versus-Host DiseaseJeffrey Yu, Barry E Storer, Kushi Kushekhar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 14, 2009
Sibling versus unrelated donor allogeneic hematopoietic cell transplantation for chronic myelogenous leukemia: refined HLA matching reveals more graft-versus-host disease but not less relapseDaniel J Weisdorf, Gene Nelson, Stephanie J Lee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 9, 2018
Employment, Insurance, and Financial Experiences of Patients with Chronic Graft-versus-Host Disease in North AmericaNandita Khera, Betty K Hamilton, Joseph A Pidala, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 22, 2020
Current Use of and Trends in Hematopoietic Cell Transplantation in the United StatesAnita D'Souza, Caitrin Fretham, Stephanie J Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2022
Axatilimab for Chronic Graft-Versus-Host Disease After Failure of at Least Two Prior Systemic Therapies: Results of a Phase I/II StudyCarrie L Kitko, Mukta Arora, Zachariah DeFilipp, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 12, 2020
Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic AnemiaMary Eapen, Mei-Jie Zhang, Xiao-Ying Tang, et al.
Pageof 17